Overall, there was a significant decrease in CIP2A as well as p-Akt and evident apoptosis (as shown by PARP cleavage) in HCC-1937 tumors treated with bortezomib, whereas no significant change was observed in control (vehicle) or MCF-7 tumors (Figure 5C). Here, AKT1 is linked to hepatocellular carcinoma.